Inmed Pharmaceuticals Inc. · NASDAQ:INM

ADAR1 Capital Management, LLC bought 42,920 Inmed Pharmaceuticals Inc. shares (Form 4)

Traded Oct 1 to Oct 5, 2026 · Filed Oct 5, 2026

From Oct 1 to Oct 5, 2026, ADAR1 Capital Management, LLC (10% owner) bought 42,920 Inmed Pharmaceuticals Inc. shares at an average US$1.33 for US$57,080, leaving 935,021 shares. Filed Oct 5, 2026 (Form 4).

Bought: 42,920 shares
Price: US$1.33 average (US$1.33 to US$1.33)
Value: US$57,080
Holding after: 935,021 shares (held indirectly)
Trading plan: No
Role: 10% owner

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Oct 1, 2026	Common Shares	Buy	16,431	US$1.33	908,532	Indirect
Oct 2, 2026	Common Shares	Buy	8,307	US$1.33	916,839	Indirect
Oct 5, 2026	Common Shares	Buy	18,182	US$1.33	935,021	Indirect

Source

View original at SEC

Related